Patient anxiety and pain levels increase during second cataract surgery

Article

A rise in pain during the second cataract extraction was linked to lower preoperative anxiety and amnestic effects of intravenous sedation, according to a study published in the Journal of Cataract and Refractive Surgery.

A rise in pain during the second cataract extraction was linked to lower preoperative anxiety and amnestic effects of intravenous sedation, according to a study published in the Journal of Cataract and Refractive Surgery.

Dr Roxana Ursea et al., Department of Ophthalmology and Vision, University of Arizona, Tucson, Arizona, USA, conducted a cohort study on 65 patients undergoing bilateral sequential clear corneal extraction. Phacoemulsification was used with topical monitored anaesthesia. Patients excluded from the results were those with baseline eye pain, poor comprehension and complicated cataract extraction. Four brief surveys were completed perioperatively including: the Amsterdam Preoperative Anxiety and Information Scale (APAIS) and the State-Trait Anxiety Scale (STAI). Postoperatively, two visual analogue scale pain surveys were completed with scores between 0 and 10.

Out of the patients, 26 had higher visual analogue scale pain scores during the second cataract operation. The average pain score for the first extraction was 0 on the scale and for the second extraction was 1. Postoperatively, the pain scores were very similar after 1 day. APAIS and STAI anxiety scores lowered between surgeries.

The pain rating recorded in the second cataract extraction was associated with decrease in patient anxiety and amnesic effects, of intravenous sedation.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.